Despite their clinical efficacy, most GLP-1-derived peptides require parenteral administration (with oral semaglutide being the exception) and frequently induce gastrointestinal adverse events that limit long-term adherence (Aroda et al., 2019
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
Impact of Toxins on P450 Enzymes and Methylation Exposure to toxins, drugs, and alcohol can impair the activity of P450 enzymes, leading to a decrease in SAMe production and impaired methylation
This physician-guided educational resource explains common subcutaneous peptide injection sites and general techniques to help patients feel better prepared for treatment
:17 mg/l
Add one new peptide per week, document your response, and only add the next when the current one is well tolerated